UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 造血細胞移植のためのドナー選定 donor selection for hematopoietic cell transplantation
2. びまん性大細胞型B細胞性リンパ腫の疫学、臨床症状、病理学的特徴、および診断 epidemiology clinical manifestations pathologic features and diagnosis of diffuse large b cell lymphoma
3. 末梢性T細胞リンパ腫の初期治療 initial treatment of peripheral t cell lymphoma
4. 鎌状赤血球症を有する女性における妊娠 pregnancy in women with sickle cell disease
5. 鎌状赤血球症を有する小児に対する定期的な包括的ケア routine comprehensive care for children with sickle cell disease

English Journal

Expansion of the Kell blood group system: two new high-prevalence antigens and two novel K0 (Kellnull ) phenotypes.

Lomas-Francis C, Vege S, Velliquette RW, Fuchisawa A, Uchikawa M, Tani Y, Moro H, Debnath AK, Westhoff CM.SourceLaboratory of Immunohematology and Genomics, New York Blood Center, New York, New York.
Transfusion.Transfusion.2013 Aug 22. doi: 10.1111/trf.12377. [Epub ahead of print]
BACKGROUND: The number of KEL alleles associated with new antigens or loss of expression of high-prevalence antigens continues to increase. We investigated KEL in five samples: two with K0 (null) phenotypes and three with normal Kell expression and antibodies to high-prevalence antigens.STUDY DESIGN
PMID 23968329

Human Leukocyte Antigen and Killer Immunoglobulin-like receptor genes as outcome predictors of hepatitis C virus-related hepatocellular carcinoma.

Cariani E, Pilli M, Zerbini A, Rota C, Olivani A, Zanelli P, Zanetti A, Trenti T, Ferrari C, Missale G.SourceClinical Pathology-Toxicology, Ospedale Civile S. Agostino-Estense.
Clinical cancer research : an official journal of the American Association for Cancer Research.Clin Cancer Res.2013 Aug 12. [Epub ahead of print]
PURPOSE: We evaluated the impact of the Killer Immunoglobulin-like Receptors (KIRs) of natural killer (NK) cells and of their Human Leukocyte Antigen (HLA) ligands over the clinical outcome of HCV-related hepatocellular carcinoma (HCC) after curative treatment by either surgical resection (SR) or ra
PMID 23938290

Fetal Red Blood Cell Hematology at Mid-Pregnancy Among Fetuses at Risk of Homozygous β-Thalassemia Disease.

Srisupundit K, Wanapirak C, Sirichotiyakul S, Tongprasert F, Luewan S, Traisrisilp K, Tongsong T.SourceDepartment of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Journal of pediatric hematology/oncology.J Pediatr Hematol Oncol.2013 Aug 7. [Epub ahead of print]
OBJECTIVE:: To compare red blood cell hematology among fetuses at risk of homozygous β-thalassemia disease at mid-pregnancy.MATERIALS AND METHODS:: Eighty-six fetuses, 18 to 22 gestational weeks, at risk of homozygous β-thalassemia disease undergoing cordocentesis between December 2010 and June 20
PMID 23887026

DNA typing of HLA class II genes in B-lymphoblastoid cell lines homozygous for HLA

DNA typing of HLA class II genes in B-lymphoblastoid cell lines homozygous for HLA

HLA ANTIGENS-ANTIBODIES SYSTEM AND ITS ASSOCIATION WITH SEVERE TOXEMIA OF PREGNANCY

FUJISAWA SATOSHI
日本産科婦人科學會雜誌 37(1), 124-130, 1985-01-01
… trimester and postpartum intra-uterine blood in women with normal deliveries were tested for Warm-T and Warm-B cell antibody against 30 panel lym phocytes. … 3) From the immunogenetic point of view, when the HLA-DR MT Iocus of a certain fetus is homozygous, the mother tends to manifest toxemia. … These results indicated that matching of HLA-DR MT Ioci in parents possibly plays a role in causing severe toxemia, and genetic prediction of its onset and prognosis can be carried out through HLA typing. …
NAID 110002190530